Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lucki

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugsJ F Cryan, A Dalvi, S H Jin, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptorsA R Allen, A Singh, Z P Zhuang, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteersP M Furlan, M J Kallan, T Ten Have, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminalsG D Stanwood, R P Artymyshyn, M P Kung, et al.
Neuroscience|June 28, 2012
Strain differences in the effects of chronic corticosterone exposure in the hippocampusG E Hodes, B R Brookshire, T E Hill-Smith, et al.
Journal of Clinical Pharmacology|April 1, 1995
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepamS M Troy, I Lucki, A A Peirgies, et al.
Neuroscience|April 17, 2010
Early life protein restriction alters dopamine circuitryZ Vucetic, K Totoki, H Schoch, et al.
Synapse (New York, N.Y.)|August 1, 1995
IPT: a novel iodinated ligand for the CNS dopamine transporterM P Kung, W D Essman, D Frederick, et al.
Journal of Neurochemistry|March 1, 1992
Brain serotonin2 and serotonin1A receptors are altered in the congenitally hyperammonemic sparse fur mouseM B Robinson, N J Anegawa, E Gorry, et al.
Journal of Clinical Psychopharmacology|June 1, 2000
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performanceS M Troy, I Lucki, M A Unruh, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugsJ F Cryan, A Dalvi, S H Jin, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptorsA R Allen, A Singh, Z P Zhuang, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteersP M Furlan, M J Kallan, T Ten Have, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminalsG D Stanwood, R P Artymyshyn, M P Kung, et al.
Neuroscience|June 28, 2012
Strain differences in the effects of chronic corticosterone exposure in the hippocampusG E Hodes, B R Brookshire, T E Hill-Smith, et al.
Journal of Clinical Pharmacology|April 1, 1995
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepamS M Troy, I Lucki, A A Peirgies, et al.
Neuroscience|April 17, 2010
Early life protein restriction alters dopamine circuitryZ Vucetic, K Totoki, H Schoch, et al.
Synapse (New York, N.Y.)|August 1, 1995
IPT: a novel iodinated ligand for the CNS dopamine transporterM P Kung, W D Essman, D Frederick, et al.
Journal of Neurochemistry|March 1, 1992
Brain serotonin2 and serotonin1A receptors are altered in the congenitally hyperammonemic sparse fur mouseM B Robinson, N J Anegawa, E Gorry, et al.
Journal of Clinical Psychopharmacology|June 1, 2000
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performanceS M Troy, I Lucki, M A Unruh, et al.
Pageof 12